Procter & Gamble Health Q3 Results
- BSE: 500126
- NSE: PGHL
- ISIN: INE199A01012
- Sector: Biotechnology & Drugs
BSE
5,527.45
-82.30 (-1.47%)
-82.30 (-1.47%)Volume93.00
Updated: Wed 9 Sep, 2026 | 09:59:48
NSE
5,540-63.00 (-1.12%)
-63.00 (-1.12%)Volume1.10 K
Updated: Wed 9 Sep, 2026 | 09:46:14
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Procter & Gamble Health Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Dec 23 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 269.30 | 215.24 | 27.79% | 191.88 | 40.34% |
| Depreciation/ Amortization | 5.90 | 6.92 | -2.96% | 6.84 | 6.31% |
| Operating Income | 104.56 | 94.73 | -8.43% | 60.60 | -11.30% |
| Net Income | 77.59 | 72.07 | -12.37% | 46.56 | -14.64% |
| Other Operating Expenses Total | 91.77 | 60.50 | 11.41% | 62.72 | 44.38% |
| Net Income Before Taxes | 108.82 | 99.72 | -8.57% | 62.72 | -10.58% |
| Total Revenue | 373.86 | 309.97 | 15.06% | 252.48 | 20.69% |
| Selling/ General/ Admin Expenses Total | 61.81 | 57.43 | 14.72% | 48.46 | 31.37% |
| Diluted Normalized EPS | 46.74 | 43.40 | -12.37% | 28.00 | -14.65% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.